Overactive bladder (OAB) is a prevalent condition characterized by urinary urgency, often accompanied by increased frequency and nocturia, affecting a significant portion of the population. In Hong Kong, a survey indicated an age-adjusted prevalence of OAB at 15.1%, highlighting the need for effective management strategies tailored to the local context. The condition can severely impact the quality of life, necessitating a comprehensive approach to diagnosis and treatment.

While the standard piecemeal transurethral resection of bladder tumor (SR) has been the conventional surgical procedure for NMIBC, oncological control remains subpar, prompting the development of alternative techniques such as en bloc transurethral resection of bladder tumor (ERBT). To examine the impact of ERBT on the prognosis of NMIBC, Professor Teoh, Yuen-Chun Jeremy and his team conducted a local phase 3 randomized controlled trial, EB-StaR, that compared the 1-year recurrence rate of NMIBC with ERBT to SR.4In an interview with Omnihealth Practice, Prof. Teoh discussed the implications of the results and the future of ERBT implementation

Type 2 diabetes (T2D) is a chronic disorder that can lead to a high disease burden and repeated hospital admissions due to its ability to facilitate a multitude of subsequent morbidities.1 Conventional studies often focus on investigating the risk of time-to-first events in T2D patients, giving limi